What is Theralogix Ovasitol, and what is it used for?
Theralogix Ovasitol is a 432 g inositol powder providing 2,000 mg of myo-inositol and 50 mg of D-chiro-inositol (DCI) per serving in a 40:1 ratio, taken twice daily for a three-month supply. It is designed for women with polycystic ovary syndrome (PCOS) to support menstrual cycle regularity, reduce insulin resistance, and improve egg quality for those trying to conceive. The 40:1 myo-inositol to DCI ratio mirrors the natural physiological ratio found in healthy human plasma and follicular fluid.
What are the key ingredients in Ovasitol and how do they work?
Two active ingredients: myo-inositol (2,000 mg) and D-chiro-inositol or DCI (50 mg) at a 40:1 ratio. Myo-inositol acts as an insulin signaling second messenger, supporting follicle-stimulating hormone (FSH) activity and ovarian function. DCI participates in insulin-mediated glucose uptake and androgen regulation. Clinical evidence supports the combination at this specific ratio — neither form alone provides equivalent outcomes. The powder is unflavored with no artificial additives.
Who should take Ovasitol, and how is it used?
Intended for women of reproductive age with PCOS seeking support for menstrual regularity, insulin sensitivity, and fertility. Dissolve one scoop twice daily — morning and evening — in any cold or warm beverage. Allow at least three months of consistent use before evaluating results. Pregnant or breastfeeding women and those on diabetes medications should consult a physician before use. Not intended for men or children.
How does Ovasitol differ from other inositol supplements for PCOS?
The clinically validated 40:1 myo-inositol to DCI ratio is the central differentiator. A trial comparing seven different inositol ratios found 40:1 most effective at restoring ovulation in PCOS patients. A comparative study found this ratio outperformed metformin for ovulation restoration (46.7% vs. 11.2%) with a 65% reduction in insulin resistance. Most inositol products provide myo-inositol alone or non-physiological ratios without clinical backing. Theralogix maintains clinical collaborations with over ten US universities including Harvard and UC Berkeley, with some trials NIH-funded.
What is TheraLogix and who is it designed for?
TheraLogix is an American nutraceutical company with over 20 years of experience specializing in reproductive and prenatal health. Its TheraNatal line is designed to support the complete reproductive journey — from preconception through pregnancy to postnatal recovery — with stage-specific formulations rather than one-size-fits-all prenatal vitamins. TheraLogix products are certified by NSF International, one of the most respected independent product testing bodies in North America. The brand's AlaskOmega DHA is sourced from wild-caught Alaska pollock from the Bering Sea and Gulf of Alaska, ensuring premium, traceable omega-3 quality.
What genuinely differentiates TheraLogix from other prenatal vitamin brands?
TheraLogix's TheraNatal line is one of the few prenatal supplement systems designed around distinct life stages: separate formulations for preconception, active pregnancy, and postnatal recovery — rather than a single formula stretched across all three. The brand's omega-3 source is AlaskOmega DHA, derived from wild-caught Alaska pollock harvested from the Bering Sea and Gulf of Alaska, offering traceable provenance that generic fish oil sources cannot provide. Over 20-plus years, TheraLogix built its reputation within the healthcare provider community rather than through mass retail marketing, making it one of the most provider-recommended prenatal brands available without a prescription.
The information provided above is for reference purposes only and has not been reviewed or approved by Health Canada. It does not constitute medical advice and should not replace consultation with a qualified healthcare professional.